Mehdi Arbabi Ghahroudi

Title: The Innovations of Mehdi Arbabi Ghahroudi

Introduction

Mehdi Arbabi Ghahroudi is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for combating bacterial infections. With a total of 2 patents to his name, his work is recognized for its potential impact on public health.

Latest Patents

One of Mehdi's latest patents focuses on anti-Campylobacter jejuni antibodies and their uses. Campylobacter jejuni is a leading cause of bacterial food-borne diseases in humans, which can lead to acute diarrheal disease and even neurological disorders. The patent describes an isolated or purified antibody or fragment that specifically binds to a flagellar protein, effectively reducing the motility of the bacteria. This antibody is derived from a heavy chain IgG variable domain fragment (VH) of a camelid animal that has been immunized with the flagellar protein. The patent also details a multivalent form and a phage format of the antibody, along with methods for reducing the presence of the bacteria in animals or their environments, as well as formulations for treating infections and methods for detection.

Career Highlights

Mehdi Arbabi Ghahroudi is affiliated with the National Research Council of Canada, where he continues to advance his research and innovations. His work is crucial in addressing the challenges posed by food-borne pathogens and improving public health outcomes.

Collaborations

Some of Mehdi's notable coworkers include Ali Riazi and Christine M Szymanski, who contribute to the collaborative efforts in their research endeavors.

Conclusion

Mehdi Arbabi Ghahroudi's contributions to the field of biotechnology, particularly through his patents on anti-Campylobacter jejuni antibodies, highlight his commitment to innovation and public health. His work exemplifies the importance of research in combating bacterial infections and improving food safety.